Reportlinker Adds Cell Screening Tools, Stem Cells and Related Analytical Products for Drug/Cell Therapy R&D
NEW YORK, Jan. 19 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:
Cell Screening Tools, Stem Cells and Related Analytical Products for Drug/Cell Therapy R&D
This report reviews, analyzes and sizes the stem cell R&D tools & tech product and stem cell therapeutic markets. The study uncovers interesting information about key equipment, consumables, reagents, software and services that are marketed to life science researchers working in stem cell R&D.
The report reviews the sources of government and private stem cell research investment. Stem cell R&D work is underway at universities, government labs, institutes, cancer centers, hospitals and at drug makers or cell therapeutics companies.
Major drug makers have taken keen interest in the potential opportunity to improve their chances for making safer future drugs by using pluripotent stem cells to make customized disease focused cells used in cell screening campaigns used in pre-clinical drug development. The customized stem cell-derived human cells would eliminate the need to sacrifice millions of lab animals that are currently used for drug safety testing.
The study examines the stem cell therapeutic market which is poised for growth within the next five years. The report reviews the current stem cell transplantation business and suggests when new stem cell based therapeutics might become available
The financial assessment section sizes the market and discusses the five year revenue projection. The market is segmented by major product areas and by major R&D disease focus. This market is also segmented by major world regions to see the growth or how the market share might change.
This study reviews and analyzes major company alliances, M&As, and patents that were issued during the last two years. Data tables summarize the alliances, M&As and patents.
This research report is designed for people that include marketers, business development, top executives, investors, VCs, consultants, R&D managers, entrepreneurs and etc. More than 41 detailed tables or figures provide key data about items such as strategic alliances, M&As, market size, segments and the like. This report includes twenty-five company profiles that provide the reader a snapshot of the companies' focus or activities. The provided Internet links help readers access companies' own web sites for further review.
Targeted Company:
Applied Precision, Inc., Axxam SpA, BD (Becton, Dickinson & Co.), Beckman Coulter, Inc.
GE Healthcare Life Sciences, Geron Corporation, Luminex Corporation, Millipore Corporation, PerkinElmer Life and Analytical Sciences, Tecan Group Ltd., ThermoFisher Scientific Inc., Consumables - Reagents, Assays, Media, Cell Lines, DiscoveRx Corporation
Life Technologies, Inc., MaxCyte, Inc., Odyssey Thera, Inc., Panomics (Affymetrix), Sigma-Aldrich, Software Solutions, Definiens AG, Stem Cell Screening/Analysis, America Stem Cell Inc., AuxoCell Laboratories, Inc., California Stem Cell, Inc., Capricor Inc., Cenix Bioscience GmbH, GIRUS Life Sciences, Inc., Fluidigm Corporation
Table of Contents
Executive Summary
1. Overview of Cell Screening and Stem Cell Tools & Technologies Market for R&D
1.1 Overview of Cell Screening and Stem Cell Tools & Techs for R&D & Therapeutics
1.1.1 Stem Cell Field Has Grown Rapidly
Figure 1. The Stem Cell R&D and Therapeutic Product Market Ecosystem
1.1.2 Definition and Brief History of Cell Screening and Stem Cell Tools & Techs for R&D & Therapeutics
Table 1. Highlights of Stem Cell Research Milestones
1.1.3 Cell Screening and Stem Cell R&D Tool & Tech Mechanisms
1.1.4 Diseases, Conditions & Demographics Targeted by R&D Using Cell Screening Tools in Stem Cell R&D
Table 2. Major Diseases by Mortality, Incidence and Prevalence
1.1.5 Tools, Technologies, Equipment & Products for Stem Cell R&D
1.1.6 Cell Screening Assays for Drug R&D
1.1.7 Stem Cell-based Therapeutics for Major Diseases
1.2 Cell Screening, Stem Cell R&D Applications
1.2.1 Basic Academic Research Applications
Figure 2. Survey of PubMed Articles Involving Stem Cells
1.2.2 Applied Research Applications
1.2.3 Pharma/ Biotech Drug R&D Applications
2. Major Alliances, M&As and IP
2.1 Summary of Key Alliances and M&As
2.1.1 Comparing Alliances and M&A's by Half-Years
Table 3. Alliances By Half-Years – Summary, '07H2-'09H1
Table 4. Alliances By Quarters – Detail, '07Q3-'09Q2
2.2 Details of Key Alliances and M&As
Table 5. Alliances, Jan-1-2009 to Jun-30-2009
Table 6. Alliances, Jul-1-2008 to Dec-31-2008
Table 7. Alliances, Jul-1-2007 to Dec-31-2007
2.3 Patents, Business Development and Challenges
2.3.1 Leading Organizations Holding Patents Involving Cell Screening and Stem Cell R&D Technologies.
Table 8. Top 20 Companies by Patents in Cell Screening and Stem Cell R&D
Table 9. Top 20 Academic Organizations by Patents in Cell Screening and Stem Cell R&D
2.3.2 Business Development and Challenges
2.3.3 IP Challenges
3. The Market and Outlook for the Cell Screening, Stem Cell Products Industry
3.1 The Total Cell Screening, Stem Cell Product Market Size, 2008~2013
3.1.1 Summary of Total Product Market Size and Growth Rate
Figure 3. WW Total Stem Cell Product Market Size
Table 10. WW Total Stem Cell Product Market Size
3.1.2 WW Total Market by Stem Cell Products By Segments
Figure 4. WW Total Stem Cell Product Market By Top Segments
Table 11. WW Total Stem Cell Product Market By Top Segments
3.2 WW Stem Cell R&D Tools & Technologies Market
3.2.1 Tools & Technologies Segments
Figure 5. WW Stem Cell R&D Tools & Techs. By Key Product Segments $M
Table 12. WW Stem Cell R&D Tools & Techs. By Key Product Segments $M
3.2.2 Methodology: Stem Cell R&D Tools & Tech. Market By Key Product Segments
3.2.3 Consumables
3.2.4 Equipment
3.2.5 Software
3.2.6 Services
3.2.7 Others
3.2.8 Stem Cell R&D Tools & Technology Key Product Segment Market Shares, 2008 & 2013
Figure 6. Stem Cell R&D Tools & Technology Key Product Segment Market Shares, 2008 & 2013
3.2.9 WW Stem Cell R&D Tools & Techs. By Product Sub-Segments $M
Table 13. WW Stem Cell R&D Tools & Techs. By Product Sub-Segments $M
3.3 WW Stem Cell R&D Tools & Technologies Market by Applications
3.3.1 Basic Research
Figure 7. WW Stem Cell R&D Tools & Technologies Market By Application $M
Table 14. WW Stem Cell R&D Tools & Technologies Market By Application $M
3.3.2 Applied R&D
3.3.3 Drug Discovery R&D
3.4 WW Stem Cell R&D Tools & Technologies Market by Disease Focus
3.4.1 Major Disease Segments
Figure 8. WW Stem Cell R&D Tools & Tech Market By Disease Focus $M
Table 15. WW Stem Cell R&D Tools & Tech Market By Disease Focus $M
3.4.2 Cancers
3.4.3 Cardiovascular
3.4.5 Hematopoietic & Transplantation
3.4.6 Respiratory
3.4.7 Liver
3.4.8 Musculoskeletal
3.4.9 Diabetes
3.4.10 Other Diseases
3.5 WW Stem Cell R&D Tools & Technologies Market by WW Regions
3.5.1 Key WW Region Segments
Figure 9. WW Stem Cell R&D Tools & Technologies Market By Region $M
Table 16. WW Stem Cell R&D Tools & Technologies Market By Region $M
3.5.2 North America
3.5.3 Europe
3.5.4 Japan/ Asia Pacific
3.5.5 ROW
3.5.6 Stem Cell R&D Tools & Technologies Region Market Shares, 2009 & 2013
Figure 10. Stem Cell R&D Tools & Technologies Region Market Shares, 2009 & 2013
3.6 WW Stem Cell Therapeutic Product Market
3.6.1 Key Therapeutics Market Segments
Figure 11. WW Stem Cell Therapeutic Market By Key Product Segments
Table 17. WW Stem Cell Therapeutic Market By Key Product Segments
3.6.2 Methodologies: Stem Cell Therapeutic Market
3.6.3 Existing Stem Transplantation
3.6.4 Near Term Adult Stem Cell-based Therapy Products
3.6.5 Future Embryonic Stem Cell-based Therapy Products
3.7 Stem Cell R&D Tools & Techs Vendor Market Share Rank (2009)
Table 18. Leading 'Equipment' Vendors by Market Share Rank
Table 19. Leading 'Consumables' Vendors by Market Share Rank
4. Activities of Selected Companies
4.1 Equipment Platforms
4.1.1 ~ 4.1.11 (Total 11 Companies)
4.2 Consumables - Reagents, Assays, Media, Cell Lines
4.2.1 ~ 4.2.6 (Total 6 Companies)
4.3 Software Solutions
4.3.1 (1 company)
4.4 Stem Cell Screening/Analysis
4.4.1 ~ 4.4.7 (Total 7 Companies)
5. Conclusions and New Business Opportunities
5.1 The Future of Cell Screening and Stem Cell R&D Products
5.1.1 Stem Cell R&D Tools & Technologies
5.1.1.1 Consumables, Stem Cells & Technologies for Stem Cell R&D
Table 20. Selected Consumables, Reagents, Stem Cells
5.1.1.2 Equipment for Stem Cell Screening
Table 21. Selected Equipment for Stem Cell Screening Software
Table 22. Selected Software for Stem Cell Screening
5.1.1.3 Software
5.1.1.4 Services
Table 23. Selected Services for Stem Cell R&D
5.1.2 Stem Cell-Based Therapeutics
Table 24. Stem Cell Therapeutic Clinical Pipeline (Phase II/III to Phase IV)
5.2 Likely Cell Screening and Stem Cell R&D Tools & Tech Success and Failure Factors
5.2.1 Widespread Public Mind-Share of Stem Cell Controversies Promotes Interest or Awareness of Stem Cell Research
5.2.2 The Challenge of Stem Cell Research Issues
5.2.3 WW Government & Private Investment in Stem Cell R&D Drive the Product Market
Table 25. WW Government & Private Investment Spending for Stem Cell R&D
5.2.4 US Presidential Election, Down Economy, Economic Stimulus
5.2.5 M&As Drive New Business for Stem Cell R&D Tool & Tech Companies
Table 26. Key M&As of Stem Cell R&D Tool & Tech Companies
5.3 Cell Screening and Stem Cell R&D Business Opportunities or Commercial Implications
5.3.1 Business Opportunities for American and European Companies
5.3.1.1 Stem Cell R&D Tools and Techs
5.3.1.2 Explore Other WW Regions for Cost Savings or New Customers
5.3.1.3 Enter Asia for Business Opportunities
5.3.2 New Business Opportunities for Japanese and Asian Companies
6. Appendix
6.1 Glossary – Life Science Terms
6.2 Key Life Science R&D Centers
Table 27. Large International Life Science R&D Centers
6.3 R&D Tool & Tech Suppliers
Table 28. Cell Screening R&D Tools & Techs. Suppliers
Table 29. Stem Cell R&D Suppliers By Product Focus
Table 30. Stem Cell Therapeutic Companies
To order this report:
Biotechnology Industry: Cell Screening Tools, Stem Cells and Related Analytical Products for Drug/Cell Therapy R&D
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article